(Q81606709)
Statements
Results of the first phase I clinical trial of the novel II-key hybrid preventive HER-2/neu peptide (AE37) vaccine (English)
Jarrod P Holmes
Linda C Benavides
Jeremy D Gates
Mark G Carmichael
Matthew T Hueman
Elizabeth A Mittendorf
James L Murray
Asna Amin
Dianna Craig
Eric von Hofe
Sathibalan Ponniah
George E Peoples